688331.SS
Price:
$104.43
Market Cap:
$58.48B
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF...[Read more]
Industry
Biotechnology
IPO Date
2022-03-31
Stock Exchange
SHH
Ticker
688331.SS
According to RemeGen Co. Ltd. Class A’s latest financial reports and current stock price. The company's current ROE is 128.12%. This represents a change of 463.08% compared to the average of 22.75% of the last 4 quarters.
The mean historical ROE of RemeGen Co. Ltd. Class A over the last ten years is 13.75%. The current 128.12% ROE has changed 831.84% with respect to the historical average. Over the past ten years (40 quarters), 688331.SS's ROE was at its highest in in the June 2026 quarter at 52.13%. The ROE was at its lowest in in the June 2020 quarter at -57.65%.
Average
13.75%
Median
-5.70%
Minimum
-73.93%
Maximum
185.49%
Discovering the peaks and valleys of RemeGen Co. Ltd. Class A ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 242.31%
Maximum Annual ROE = 185.49%
Minimum Annual Increase = -350.20%
Minimum Annual ROE = -73.93%
| Year | ROE | Change |
|---|---|---|
| 2025 | 19.66% | -126.60% |
| 2024 | -73.93% | 68.15% |
| 2023 | -43.97% | 119.22% |
| 2022 | -20.06% | -350.20% |
| 2021 | 8.02% | -141.29% |
| 2020 | -19.41% | -110.47% |
| 2019 | 185.49% | 242.31% |
The current ROE of RemeGen Co. Ltd. Class A (688331.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-32.74%
5-year avg
-22.05%
10-year avg
13.75%
RemeGen Co. Ltd. Class A’s ROE is less than BeOne Medicines Ltd. Class A (14.27%), greater than Shanghai Junshi Biosciences Co., Ltd. (-7.32%), less than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (39.15%), less than Shanghai Allist Pharmaceuticals Co., Ltd. (36.69%), less than Jiangsu Hengrui Medicine Co., Ltd. (12.42%), less than Sichuan Kelun Pharmaceutical Co., Ltd. Class A (7.53%), less than Suzhou Zelgen Biopharmaceuticals Co., Ltd. (39.00%), greater than Mabwell (Shanghai) Bioscience Co., Ltd. (-179.93%), less than Evopoint Biosciences Co. Ltd. (0%),
| Company | ROE | Market cap |
|---|---|---|
| 14.27% | $276.82B | |
| -7.32% | $27.92B | |
| 39.15% | $32.08B | |
| 36.69% | $36.85B | |
| 12.42% | $300.13B | |
| 7.53% | $65.30B | |
| 39.00% | $25.82B | |
| -179.93% | $9.20B | |
| 0% | $20.29B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RemeGen Co. Ltd. Class A using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RemeGen Co. Ltd. Class A or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is RemeGen Co. Ltd. Class A's ROE?
How is the ROE calculated for RemeGen Co. Ltd. Class A (688331.SS)?
What is the highest ROE for RemeGen Co. Ltd. Class A (688331.SS)?
What is the 3-year average ROE for RemeGen Co. Ltd. Class A (688331.SS)?
What is the 5-year average ROE for RemeGen Co. Ltd. Class A (688331.SS)?
How does the current ROE for RemeGen Co. Ltd. Class A (688331.SS) compare to its historical average?